BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37177856)

  • 1. Validation of newly derived polygenic risk scores for dementia in a prospective study of older individuals.
    Yu C; Ryan J; Orchard SG; Robb C; Woods RL; Wolfe R; Renton AE; Goate AM; Brodtmann A; Shah RC; Chong TT; Sheets K; Kyndt C; Sood A; Storey E; Murray AM; McNeil JJ; Lacaze P
    Alzheimers Dement; 2023 Dec; 19(12):5333-5342. PubMed ID: 37177856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
    Najar J; Thorvaldsson V; Kern S; Skoog J; Waern M; Zetterberg H; Blennow K; Skoog I; Zettergren A
    Neurobiol Dis; 2023 Dec; 189():106357. PubMed ID: 37977433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years.
    Stocker H; Perna L; Weigl K; Möllers T; Schöttker B; Thomsen H; Holleczek B; Rujescu D; Brenner H
    Mol Psychiatry; 2021 Oct; 26(10):5812-5822. PubMed ID: 32404947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
    Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
    Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
    Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of
    Xicota L; Gyorgy B; Grenier-Boley B; Lecoeur A; Fontaine G; Danjou F; Gonzalez JS; Colliot O; Amouyel P; Martin G; Levy M; Villain N; Habert MO; Dubois B; Lambert JC; Potier MC;
    Neurology; 2022 Aug; 99(5):e462-e475. PubMed ID: 35606148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
    Kikuchi M; Miyashita A; Hara N; Kasuga K; Saito Y; Murayama S; Kakita A; Akatsu H; Ozaki K; Niida S; Kuwano R; Iwatsubo T; Nakaya A; Ikeuchi T; ;
    Alzheimers Res Ther; 2024 Feb; 16(1):45. PubMed ID: 38414085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic risk of Alzheimer's disease in the Faroe Islands.
    Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
    Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
    Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
    BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia.
    Littlejohns TJ; Collister JA; Liu X; Clifton L; Tapela NM; Hunter DJ
    Alzheimers Dement; 2023 Feb; 19(2):467-476. PubMed ID: 35439339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes.
    Jung SH; Kim HR; Chun MY; Jang H; Cho M; Kim B; Kim S; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Jang JW; Kim Y; Hong JY; Choi SH; Noh Y; Kim KW; Kim SE; Lee JS; Jung NY; Lee J; Lee AY; Kim BC; Cho SH; Cho H; Kim JH; Jung YH; Lee DY; Lee JH; Lee ES; Kim SJ; Moon SY; Son SJ; Hong CH; Bae JS; Lee S; Na DL; Seo SW; Cruchaga C; Kim HJ; Won HH
    JAMA Netw Open; 2022 Dec; 5(12):e2247162. PubMed ID: 36520433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives.
    Najar J; van der Lee SJ; Joas E; Wetterberg H; Hardy J; Guerreiro R; Bras J; Waern M; Kern S; Zetterberg H; Blennow K; Skoog I; Zettergren A
    Alzheimers Dement (Amst); 2021; 13(1):e12142. PubMed ID: 33532541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: A population-based prospective cohort study.
    Chen Y; Zhang Y; Li S; Zhou L; Li H; Li D; Wang Y; Yang H
    Arch Gerontol Geriatr; 2023 Feb; 105():104853. PubMed ID: 36347157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Polygenic Risk Score for Alzheimer's Disease in Russian Patients with Dementia Using a Low-Density Hydrogel Oligonucleotide Microarray.
    Ikonnikova A; Morozova A; Antonova O; Ochneva A; Fedoseeva E; Abramova O; Emelyanova M; Filippova M; Morozova I; Zorkina Y; Syunyakov T; Andryushchenko A; Andreuyk D; Kostyuk G; Gryadunov D
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults.
    Thompson LI; Cummings M; Emrani S; Libon DJ; Ang A; Karjadi C; Au R; Liu C
    J Prev Alzheimers Dis; 2024; 11(1):79-87. PubMed ID: 38230720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Performance of a Polygenic Risk Score for Incident Ischemic Stroke in a Healthy Older Population.
    Neumann JT; Riaz M; Bakshi A; Polekhina G; Thao LTP; Nelson MR; Woods RL; Abraham G; Inouye M; Reid CM; Tonkin AM; Williamson JD; Donnan GA; Brodtmann A; Cloud GC; McNeil JJ; Lacaze P
    Stroke; 2021 Aug; 52(9):2882-2891. PubMed ID: 34039031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations.
    Li F; Xie S; Cui J; Li Y; Li T; Wang Y; Jia J
    J Prev Alzheimers Dis; 2024; 11(3):701-709. PubMed ID: 38706286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Gorijala P; Aslam MM; Dang LT; Xicota L; Fernandez MV; Sung YJ; Fan KH; Feingold E; Surace EI; Chhatwal JP; Hom CL; ; ; Hartley SL; Hassenstab J; Perrin RJ; Mapstone M; Zaman SH; Ances BM; Kamboh MI; Lee JH; Cruchaga C
    Alzheimers Dement; 2024 Feb; 20(2):1038-1049. PubMed ID: 37855447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.